AKIRA is more than your average deathmatch performer.

North Yorkshire-headquartered rural land and property specialist, GSC Grays, has strengthened its leadership team with three senior appointments. Janine Tompkins has been appointed chief operating ...

Q4 2024 Earnings Call Transcript March 4, 2025 Wave Life Sciences Ltd. beats earnings expectations. Reported EPS is $0.17, expectations were $-0.17. Operator: Good morning and welcome to the Wave Life ...

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

The NICE scientific advice service includes a standard ... market access. Great job!” For PRIMA, the agency quotes Peter Wheatley-Price, market access and pricing director at Takeda UK, who ...

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 V ...

Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

Takeda and Protagonist Therapeutics have reported positive topline outcomes from their Phase III VERIFY trial of rusfertide ...

More than 120 entries have been whittled down to the top 25 women aged under 40 tipped to spearhead the next generation of leading partners.

The base Jeep Grand Cherokee Laredo A starts at $36,495 and features a spacious interior along with great standard equipment. Its performance and list of amenities don’t stand out among ...